TrialVilamakitug in Spondyloarthritis Placebo-controlled Investigation for Efficacy
Trial details
- Registry ID
- NCT06526377
- Phase
- Phase 2
Drug research
vilamakitug
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as Natrunix; XB2001
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Vilamakitug in Spondyloarthritis Placebo-controlled Investigation for EfficacyNCT06526377 | XBIT | Phase 2 | Not yet recruiting | 2028-09Estimated |
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |